Northwestern University/Northwestern Medical Faculty Foundation

Chicago, Illinois 60611-3013

0 studies enrolling now · 11 studies all time

What they study most

Advanced Nonsmall Cell Lung Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Chronic Rhinosinusitis, Colorectal Cancer, Dermatitis, Atopic Dermatitis, Leukemia, Lymphoma, Metastatic Breast Cancer, Metastatic Non Small Cell Lung Cancer, Plaque Psoriasis

Studies at this site

• Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis. — Completed
• A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL — Completed
• Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis — Completed
• Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer — Completed
• Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer — Completed
• Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome — Completed
• Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma — Completed
• Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer — Stopped early
• Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer — Completed
• Point-of-Care Computed Tomography (CT) Chronic Rhinosinusitis Study — Completed
• Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib — Completed